Rothschild Investment Corp IL grew its position in Danaher Corporation (NYSE:DHR) by 52.7% during the third quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 18,507 shares of the company’s stock after purchasing an additional 6,388 shares during the quarter. Rothschild Investment Corp IL’s holdings in Danaher Corporation were worth $1,588,000 at the end of the most recent reporting period.
A number of other large investors also recently made changes to their positions in the stock. GQG Partners LLC purchased a new stake in Danaher Corporation during the second quarter worth about $101,000. Proficio Capital Partners LLC increased its position in Danaher Corporation by 92.3% during the first quarter. Proficio Capital Partners LLC now owns 1,246 shares of the company’s stock worth $105,000 after purchasing an additional 598 shares during the last quarter. Monetary Management Group Inc. grew its stake in Danaher Corporation by 10.7% during the second quarter. Monetary Management Group Inc. now owns 1,550 shares of the company’s stock worth $131,000 after buying an additional 150 shares during the period. Acrospire Investment Management LLC grew its stake in Danaher Corporation by 185.5% during the second quarter. Acrospire Investment Management LLC now owns 1,693 shares of the company’s stock worth $143,000 after buying an additional 1,100 shares during the period. Finally, ClariVest Asset Management LLC purchased a new stake in Danaher Corporation during the first quarter worth approximately $157,000. Hedge funds and other institutional investors own 75.38% of the company’s stock.
In other Danaher Corporation news, insider William King sold 43,688 shares of the business’s stock in a transaction on Thursday, August 31st. The stock was sold at an average price of C$82.86, for a total value of C$3,619,987.68. Following the transaction, the insider now owns 45,748 shares of the company’s stock, valued at C$3,790,679.28. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, Director Donald J. Ehrlich sold 10,578 shares of the business’s stock in a transaction on Tuesday, October 24th. The stock was sold at an average price of C$90.82, for a total value of C$960,693.96. Following the completion of the transaction, the director now directly owns 104,621 shares in the company, valued at approximately C$9,501,679.22. The disclosure for this sale can be found here. Over the last quarter, insiders sold 279,628 shares of company stock valued at $25,304,394. 12.20% of the stock is currently owned by corporate insiders.
A number of research analysts have commented on the stock. J P Morgan Chase & Co reiterated an “overweight” rating and set a $95.00 price objective on shares of Danaher Corporation in a research note on Friday, September 8th. Wells Fargo & Company reaffirmed a “market perform” rating on shares of Danaher Corporation in a report on Saturday, July 22nd. Zacks Investment Research raised shares of Danaher Corporation from a “hold” rating to a “buy” rating and set a $97.00 price objective on the stock in a report on Thursday, October 5th. Citigroup Inc. set a $96.00 target price on shares of Danaher Corporation and gave the company a “buy” rating in a research note on Friday, July 21st. Finally, Morgan Stanley restated an “overweight” rating and set a $95.00 price objective (up previously from $86.00) on shares of Danaher Corporation in a research report on Friday, October 6th. One equities research analyst has rated the stock with a sell rating, four have given a hold rating, thirteen have assigned a buy rating and one has given a strong buy rating to the company’s stock. The stock presently has an average rating of “Buy” and a consensus target price of C$93.31.
ILLEGAL ACTIVITY WARNING: “Rothschild Investment Corp IL Acquires 6,388 Shares of Danaher Corporation (DHR)” was first published by Markets Daily and is the sole property of of Markets Daily. If you are reading this piece on another website, it was illegally stolen and reposted in violation of US & international copyright & trademark laws. The correct version of this piece can be read at https://www.themarketsdaily.com/2017/11/13/rothschild-investment-corp-il-acquires-6388-shares-of-danaher-corporation-dhr.html.
Shares of Danaher Corporation (NYSE DHR) opened at C$92.24 on Monday. The stock has a market capitalization of $64,162.62, a price-to-earnings ratio of 23.71, a PEG ratio of 2.19 and a beta of 1.02. The company has a current ratio of 1.43, a quick ratio of 1.00 and a debt-to-equity ratio of 0.42. Danaher Corporation has a 1-year low of C$76.27 and a 1-year high of C$93.36.
Danaher Corporation (NYSE:DHR) last issued its quarterly earnings data on Thursday, October 19th. The company reported C$1.00 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of C$0.95 by C$0.05. Danaher Corporation had a return on equity of 11.29% and a net margin of 13.36%. The company had revenue of C$4.53 billion during the quarter, compared to the consensus estimate of C$4.47 billion. During the same period last year, the company earned $0.87 earnings per share. The firm’s revenue was up 9.6% compared to the same quarter last year. research analysts anticipate that Danaher Corporation will post 3.99 earnings per share for the current year.
The firm also recently announced a quarterly dividend, which was paid on Friday, October 27th. Shareholders of record on Friday, September 29th were issued a $0.14 dividend. The ex-dividend date of this dividend was Thursday, September 28th. This represents a $0.56 dividend on an annualized basis and a yield of 0.61%. Danaher Corporation’s payout ratio is currently 16.52%.
About Danaher Corporation
Danaher Corporation (Danaher) designs, manufactures and markets professional, medical, industrial and commercial products and services. The Company operates through four segments: Life Sciences, which offers a range of research tools that scientists use to study the basic building blocks of life, including genes, proteins, metabolites and cells, in order to understand the causes of disease, identify new therapies and test new drugs and vaccines; Diagnostics; which offers analytical instruments, reagents, consumables, software and services; Dental, which provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone, and Environmental & Applied Solutions, which consists of various lines of business, including water quality and product identification.
Receive News & Ratings for Danaher Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher Corporation and related companies with MarketBeat.com's FREE daily email newsletter.